ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,791Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1383

$1.09M Total Retail Price of All Prescriptions

Rank: 42 out of 1383

922 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 922 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

27% of this provider’s 922 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 18,711 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,416 981 S3 1 1
FUROSEMIDE 933 732 2 7
LEVOTHYROXINE SODIUM 730 565 3 4
POTASSIUM CHLORIDE 695 526 4 12
METFORMIN HCL 642 443 5 8
SIMVASTATIN 637 459 6 2
OMEPRAZOLE 618 426 7 5
METOPROLOL TARTRATE 588 430 8 9
LISINOPRIL 586 442 9 3
HYDROCHLOROTHIAZIDE 569 386 10 10
GABAPENTIN 564 357 11 11
RANITIDINE HCL 542 356 12 19
AMLODIPINE BESYLATE 503 332 13 6
ATENOLOL 457 335 14 16
TAMSULOSIN HCL 448 313 15 30
BENAZEPRIL HCL 443 318 16 38
LOVASTATIN 428 288 17 22
CITALOPRAM HBR 405 290 18 15
PREDNISONE 337 233 19 40
ZOLPIDEM TARTRATE 337 239 19 17
SERTRALINE HCL 321 216 21 21
DONEPEZIL HCL 261 234 22 35
CARVEDILOL 258 165 23 24
NAMENDA 256 238 24 49
WARFARIN SODIUM 246 199 25 13
PRAVASTATIN SODIUM 244 202 26 14
MELOXICAM 237 181 27 20
CLOPIDOGREL 233 180 28 28
NEXIUM 223 181 29 26
PANTOPRAZOLE SODIUM 212 126 30 32
FLUTICASONE PROPIONATE 204 117 31 39
TRAMADOL HCL 197 134 32 25
GLIMEPIRIDE 196 130 33 31
ALENDRONATE SODIUM 193 173 34 37
DIVALPROEX SODIUM 192 138 35 78
FAMOTIDINE 167 129 36 61
PLAVIX 166 136 37 43
FLUOXETINE HCL 159 136 38 52
DIGOXIN 156 120 39 59
CLONIDINE HCL 154 107 40 44
PROAIR HFA 153 114 41 42
DIOVAN 150 123 42 58
QUETIAPINE FUMARATE 146 119 43 70
PHENYTOIN SODIUM EXTENDED 145 95 44 137
FENOFIBRATE 141 105 45 65
RAMIPRIL 138 91 46 80
CRESTOR 137 87 47 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 77 48 27
SPIRIVA 134 72 49 45
MIRTAZAPINE 122 72 50 51
ADVAIR DISKUS 118 67 51 63
TRAZODONE HCL 117 65 52 36
ATORVASTATIN CALCIUM 115 74 53 18
CIPROFLOXACIN HCL 114 81 54 54
PROMETHAZINE HCL 114 73 R 54 56
POLYETHYLENE GLYCOL 3350 113 85 56 64
LANTUS 109 75 57 50
DILTIAZEM 24HR CD 108 85 58 95
MEGESTROL ACETATE 106 92 R 59 170
BACLOFEN 105 17 60 118
AMOXICILLIN 105 57 60 119
SEROQUEL XR 104 57 62 250
AZITHROMYCIN 101 64 63 41
PRAMIPEXOLE DIHYDROCHLORIDE 99 94 64 160
RISPERIDONE 98 74 65 71
VENLAFAXINE HCL ER 94 66 66 102
CYCLOBENZAPRINE HCL 93 30 R 67 69
GLYBURIDE 92 73 R 68 46
NITROGLYCERIN PATCH 91 79 69 177
THEOPHYLLINE ANHYDROUS 88 80 70 196
PAROXETINE HCL 88 74 70 55
FENTANYL 88 61 S2 70 92
BENAZEPRIL-HYDROCHLOROTHIAZIDE 87 51 73 144
AMOX TR-POTASSIUM CLAVULANATE 86 56 74 106
BUSPIRONE HCL 86 61 74 109
FINASTERIDE 85 50 76 121
DIVALPROEX SODIUM ER 83 77 77 200
CYMBALTA 81 48 78 53
ALLOPURINOL 80 43 79 33
TERAZOSIN HCL 80 54 79 111
OXYBUTYNIN CHLORIDE 73 32 81 115
DILTIAZEM ER 73 51 81 110
DIOVAN HCT 71 67 83 103
ZIPRASIDONE HCL 71 46 83 232
HYDRALAZINE HCL 70 54 85 86
COMBIVENT 68 47 86 116
LYRICA 68 24 86 72
VERAPAMIL ER 68 45 86 84
CARBIDOPA-LEVODOPA 67 67 89 108
SEROQUEL 65 55 90 130
ZETIA 64 40 91 101
OXYCODONE HCL-ACETAMINOPHEN 63 27 S2 92 81
EXELON 62 62 93 117
INSULIN SYRINGE 62 40 93 83
ACETAMINOPHEN-CODEINE 62 37 S3 93 163
BUMETANIDE 62 39 93 122
SPIRONOLACTONE 60 41 97 67
KLOR-CON M20 60 27 97 100
NYSTATIN 60 45 97 132
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 47 100 89
SYNTHROID 58 0 101 73
MECLIZINE HCL 58 52 101 113
GEODON 58 37 101 301
LEVEMIR 55 32 104 145
TIZANIDINE HCL 54 0 105 104
LOSARTAN POTASSIUM 54 29 105 23
METFORMIN HCL ER 54 15 105 47
AGGRENOX 52 37 108 191
NOVOLOG MIX 70-30 51 21 109 273
ISOSORBIDE MONONITRATE ER 51 48 109 66
PROPRANOLOL HCL 51 34 109 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.